You are viewing an incomplete version of our website. Please click to reload the website as full version.

Browse our anti-RIPK1 (RIPK1) Antibodies

Full name:
anti-Receptor (TNFRSF)-Interacting serine-threonine Kinase 1 Antibodies (RIPK1)
On www.antibodies-online.com are 123 Receptor (TNFRSF)-Interacting serine-threonine Kinase 1 (RIPK1) Antibodies from 24 different suppliers available. Additionally we are shipping RIPK1 Kits (13) and RIPK1 Proteins (12) and many more products for this protein. A total of 159 RIPK1 products are currently listed.
Synonyms:
2400006N03Rik, C9orf12, D330015H01Rik, RGD1311271, Rinp, Rip, Rip1, rIpk1, RP23-83I13.5
list all antibodies Gene Name GeneID UniProt
RIPK1 306808 Q5PXE9
RIPK1 8737 Q13546
RIPK1 19766 Q60855

Show all species

Show all synonyms

Most Popular Reactivities for anti-RIPK1 (RIPK1) Antibodies

Select your species and application

anti-Rat (Rattus) RIPK1 Antibodies:

anti-Human RIPK1 Antibodies:

anti-Mouse (Murine) RIPK1 Antibodies:

All available anti-RIPK1 Antibodies

Go to our pre-filtered search.

Top referenced anti-RIPK1 Antibodies

  1. Chicken Monoclonal RIPK1 Primary Antibody for IF, IP - ABIN967984 : Takahashi, Tanaka, Brannan, Jenkins, Copeland, Suda, Nagata: Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. in Cell 1994 (PubMed)
    Show all 5 references for ABIN967984

  2. Human Polyclonal RIPK1 Primary Antibody for EIA, IHC (p) - ABIN500614 : Hsu, Huang, Shu, Baichwal, Goeddel: TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex. in Immunity 1996 (PubMed)
    Show all 4 references for ABIN500614

  3. Human Polyclonal RIPK1 Primary Antibody for ELISA, ICC - ABIN4350584 : Nilsson, Loganathan, Sekiguchi, Matsuba, Hui, Tsubuki, Tanaka, Iwata, Saito, Saido: Aβ secretion and plaque formation depend on autophagy. in Cell reports 2013 (PubMed)
    Show all 3 references for ABIN4350584

  4. Human Polyclonal RIPK1 Primary Antibody for IHC (p), WB - ABIN657814 : Kim, Ohoka, Okuhira, Sai, Nishimaki-Mogami, Naito: Modulation of RIP1 ubiquitylation and distribution by MeBS to sensitize cancer cells to tumor necrosis factor α-induced apoptosis. in Cancer science 2010 (PubMed)
    Show all 2 references for ABIN657814

  5. Human Polyclonal RIPK1 Primary Antibody for IHC (fro), IHC (p) - ABIN127073 : Stanger, Leder, Lee, Kim, Seed: RIP: a novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death. in Cell 1995 (PubMed)
    Show all 2 references for ABIN127073

  6. Human Polyclonal RIPK1 Primary Antibody for ICC, IF - ABIN4350585 : Hirsch, von der Wall, Hummel, Dürkop: RIP1 expression is necessary for CD30-mediated cell death induction in anaplastic large-cell lymphoma cells. in Laboratory investigation; a journal of technical methods and pathology 2013 (PubMed)

  7. Human Polyclonal RIPK1 Primary Antibody for IHC, IHC (p) - ABIN4350581 : Ratovitski: Phospho-ΔNp63α-responsive microRNAs contribute to the regulation of necroptosis in squamous cell carcinoma upon cisplatin exposure. in FEBS letters 2015 (PubMed)

  8. Cow (Bovine) Polyclonal RIPK1 Primary Antibody for WB - ABIN2792131 : Kurenova, Xu, Yang, Baldwin, Craven, Hanks, Liu, Cance: Focal adhesion kinase suppresses apoptosis by binding to the death domain of receptor-interacting protein. in Molecular and cellular biology 2004 (PubMed)

More Antibodies against RIPK1 Interaction Partners

Human Receptor (TNFRSF)-Interacting serine-threonine Kinase 1 (RIPK1) interaction partners

  1. Data indicate that RIP-1 (show UQCRFS1 Antibodies) promote the growth and invasion of gastric cancer in vitro and in vivo, additionally providing evidence that targeting RIP-1 (show UQCRFS1 Antibodies) may be useful in the treatment of gastric cancer.

  2. High expression of RIP1 (show UQCRFS1 Antibodies) is associated with hepatocellular carcinoma.

  3. Upregulated expression of RIP1 (show UQCRFS1 Antibodies) is associated with triple-negative breast cancer.

  4. Innate immune signaling through differential RIPK1 expression promote tumor progression in head and neck squamous cell carcinoma.

  5. Hyperglycemic Conditions Prime Cells for RIP1 (show UQCRFS1 Antibodies)-dependent Necroptosis.

  6. In contrast, both necrostatin-1, a RIP1 (show UQCRFS1 Antibodies) kinase inhibitor, and Enbrel, a TNFalpha (show TNF Antibodies)-blocking antibody, do not interfere with BV6/Drozitumab-induced apoptosis, demonstrating that apoptosis occurs independently of RIP1 (show UQCRFS1 Antibodies) kinase activity or an autocrine TNFalpha (show TNF Antibodies) loop.

  7. Report role of RIP1 (show UQCRFS1 Antibodies) in Smac (show DIABLO Antibodies) mimetic mediated chemosensitization of neuroblastoma (show ARHGEF16 Antibodies) cells.

  8. By promoting both inflammation and cell death, RIPK1 may be a common mediator of axonal pathology in amyotrophic lateral sclerosis.

  9. Down-regulating RIP1 (show UQCRFS1 Antibodies) promotes oxaliplatin induced Tca8113 cells apoptosis

  10. RIPK1 and RIPK2 (show RIPK2 Antibodies) are targets of HIV-1 Protease activity during infection, and their inactivation may contribute to modulation of cell death and host defense pathways by HIV-1

Mouse (Murine) Receptor (TNFRSF)-Interacting serine-threonine Kinase 1 (RIPK1) interaction partners

  1. Hyperglycemic Conditions Prime Cells for RIP1 (show RALBP1 Antibodies)-dependent Necroptosis.

  2. our study suggests that nicotine may induce murine spermatozoal apoptosis via the TNF (show TNF Antibodies) apoptotic pathway through up-regulation of deubiquitinated RIP1 (show RALBP1 Antibodies) by Trim27 (show RFP Antibodies) promoter hypomethylation.

  3. CNOT3 (show CNOT3 Antibodies) suppression promotes necroptosis by stabilizing mRNAs for cell death-inducing proteins, Ripk1 and Ripk3 (show RIPK3 Antibodies).

  4. TAKI-induced cytotoxicity is cell context specific, and apoptosis observed in macrophages is dependent on the constitutive autocrine action of TNF-alpha (show TNF Antibodies) for RIP1 (show RALBP1 Antibodies) activation and ROS (show ROS1 Antibodies) production.

  5. RIP1 (show RALBP1 Antibodies)-Tag2 mice that lack serglycin (show SRGN Antibodies) develop larger tumors.

  6. Data show that NEMO (show IKBKG Antibodies) protein prevents hepatocarcinogenesis by inhibiting receptor (TNFRSF)-interacting serine-threonine kinase 1 (RIPK1) kinase activity-driven hepatocyte apoptosis.

  7. data show that RIP1 (show RALBP1 Antibodies)-mediated necroptosis is not present in the postischemic liver and that I/R-induced caspase (show CASP3 Antibodies) activation is associated with loss of RIP1 (show RALBP1 Antibodies) expression

  8. In addition to other pro-death functions, RIP1 (show RALBP1 Antibodies) regulates cellular sensitivity to pro-death stimuli by modulating basal autophagy.

  9. Cisplatin stimulates RIP1/RP3/MLKL-dependent necrotic cell death in renal tubules, which finally causes renal dysfunction

  10. diverse modes of acute liver injury have differing requirements for RIP1 (show RALBP1 Antibodies) and RIP3 (show MPRIP Antibodies); moreover, within a single injury model, RIP1 (show RALBP1 Antibodies) and RIP3 (show MPRIP Antibodies) blockade can have diametrically opposite effects on tissue damage

RIPK1 Antigen Profile

Antigen Summary

Serine-threonine kinase which transduces inflammatory and cell-death signals (necroptosis) following death receptors ligation, activation of pathogen recognition receptors (PRRs), and DNA damage. Upon activation of TNFR1 by the TNF-alpha family cytokines, TRADD and TRAF2 are recruited to the receptor. Ubiquitination by TRAF2 via 'Lys-63'-link chains acts as a critical enhancer of communication with downstream signal transducers in the mitogen-activated protein kinase pathway and the NF-kappa-B pathway, which in turn mediate downstream events including the activation of genes encoding inflammatory molecules. Polyubiquitinated protein binds to IKBKG/NEMO, the regulatory subunit of the IKK complex, a critical event for NF-kappa-B activation. Interaction with other cellular RHIM-containing adapters initiates gene activation and cell death. RIPK1 and RIPK3 association, in particular, forms a necroptosis-inducing complex.

Alternative names and synonyms associated with RIPK1

  • receptor (TNFRSF)-interacting serine-threonine kinase 1 (LOC100230522) antibody
  • inositol 1,3,4,5,6-pentakisphosphate 2-kinase (Ippk) antibody
  • receptor (TNFRSF)-interacting serine-threonine kinase 1 (RIPK1) antibody
  • receptor (TNFRSF)-interacting serine-threonine kinase 1 (Ripk1) antibody
  • RPA interacting protein (Rpain) antibody
  • 2400006N03Rik antibody
  • C9orf12 antibody
  • D330015H01Rik antibody
  • RGD1311271 antibody
  • Rinp antibody
  • Rip antibody
  • Rip1 antibody
  • rIpk1 antibody
  • RP23-83I13.5 antibody

Protein level used designations for RIPK1

receptor (TNFRSF)-interacting serine-threonine kinase 1 , 1,3,4,5,6-pentakisphosphate 2-kinase , inositol polyphosphate kinase 1 , inositol-1,3,4,5,6-pentakisphosphate 2-kinase , inositol-pentakisphosphate 2-kinase , ins(1,3,4,5,6)P5 2-kinase , insP5 2-kinase , RIP-1 , cell death protein RIP , receptor interacting protein , receptor-interacting protein 1 , receptor-interacting serine/threonine-protein kinase 1 , serine/threonine-protein kinase RIP , RPA interacting protein delta 2 , RPA interacting protein epsilon , RPA-interacting protein

GENE ID SPECIES
100230522 Taeniopygia guttata
306808 Rattus norvegicus
8737 Homo sapiens
504727 Bos taurus
100524751 Sus scrofa
19766 Mus musculus
306886 Rattus norvegicus
69723 Mus musculus
Selected quality suppliers for anti-RIPK1 (RIPK1) Antibodies
Did you look for something else?